Chamindie Punyadeera

Last updated
Chamindie Punyadeera
EducationPhD (University of The Witwatersrand, Johannesburg)
OccupationResearcher
EmployerQUT
Known forBiomedical health
TitleProfessor

Chamindie Punyadeera FTSE is a researcher at QUT, who was selected to be a Fellow of the Australian Academy of Technology, Science and Engineering in 2023. She is a researcher in cancer and heart disease, leading a team who uses human saliva and blood as diagnostic tools for detecting heart disease and cancer early. [1] [2]

Contents

Early career

Punyadeera was born in Sri Lanka, and was raised in Botswana. [3] She received a Bachelor of Science from the University of Botswana, 1994, followed by a Masters of Science in 1996, and a PhD in 2000, both from the University of the Witwatersrand. [4]

Career

Punyadeera has worked as a translational scientist across biomedicine and engineering, with research experience in both industry and academia. She worked in Philips Electronics in the Netherlands, where she played a role in the development of the Philips Mini-care I-20, an invention for the detection of cardiac diseases.

Punyadeera's research also includes studies on nucleic acid detection. She contributed to the creation of an integrated platform known as Idylla TM, which was subsequently commercialized by Biocartis NV in Belgium.

Punyadeera has worked in salivary diagnostics, and her research has resulted in FDA approval for a breakthrough saliva-based testing technology in the United States. She leads a research laboratory in Australia, with a team of over 13 researchers working on liquid biopsy assays aimed at improving cancer treatment precision. She also organized the first saliva conference in Australasia in 2016. [1]

Her research output includes as at 2023, more than 110 publications, 7 invited book chapters, and more than 5300 citations, with h-index of 40. Additionally, she has also filed 17 PCT applications and has licensed a saliva biomarker panel to ESN Cleer in Australia. [5] [6]

Punyadeera plays an editorial role in publications, such as the Journal of Oral Oncology, Pharmacogenomics Research and Personalized Medicine, and serves as an associate editor for BMC Medical Genomics and BMC Cancer.

“Nothing in life is to be feared. It is only to be understood,” are words that I live by. Spoken by Marie Curie, the Polish physicist and chemist who was the first woman to win a Nobel Peace Prize in Chemistry, a pioneering researcher in radioactivity who conducted her study in appalling conditions." [3]

Publications

Awards

Related Research Articles

<span class="mw-page-title-main">Sjögren syndrome</span> Autoimmune disease, affecting our moisture-producing glands esp. kidneys, liver, et al.

Sjögren syndrome or Sjögren's syndrome is a long-term autoimmune disease that affects the body's moisture-producing glands, and often seriously affects other organ systems, such as the lungs, kidneys, and nervous system.

<span class="mw-page-title-main">Saliva</span> Bodily fluid secreted by salivary glands

Saliva is an extracellular fluid produced and secreted by salivary glands in the mouth. In humans, saliva is around 99% water, plus electrolytes, mucus, white blood cells, epithelial cells, enzymes, antimicrobial agents.

Dysgeusia, also known as parageusia, is a distortion of the sense of taste. Dysgeusia is also often associated with ageusia, which is the complete lack of taste, and hypogeusia, which is a decrease in taste sensitivity. An alteration in taste or smell may be a secondary process in various disease states, or it may be the primary symptom. The distortion in the sense of taste is the only symptom, and diagnosis is usually complicated since the sense of taste is tied together with other sensory systems. Common causes of dysgeusia include chemotherapy, asthma treatment with albuterol, and zinc deficiency. Liver disease, hypothyroidism, and rarely certain types of seizures can also lead to dysgeusia. Different drugs could also be responsible for altering taste and resulting in dysgeusia. Due to the variety of causes of dysgeusia, there are many possible treatments that are effective in alleviating or terminating the symptoms of dysgeusia. These include artificial saliva, pilocarpine, zinc supplementation, alterations in drug therapy, and alpha lipoic acid.

<span class="mw-page-title-main">Salivary gland</span> Exocrine glands that produce saliva through a system of ducts

The salivary glands in many vertebrates including mammals are exocrine glands that produce saliva through a system of ducts. Humans have three paired major salivary glands, as well as hundreds of minor salivary glands. Salivary glands can be classified as serous, mucous, or seromucous (mixed).

<span class="mw-page-title-main">Parotid gland</span> Major salivary gland in many animals

The parotid gland is a major salivary gland in many animals. In humans, the two parotid glands are present on either side of the mouth and in front of both ears. They are the largest of the salivary glands. Each parotid is wrapped around the mandibular ramus, and secretes serous saliva through the parotid duct into the mouth, to facilitate mastication and swallowing and to begin the digestion of starches. There are also two other types of salivary glands; they are submandibular and sublingual glands. Sometimes accessory parotid glands are found close to the main parotid glands.

<span class="mw-page-title-main">Oral cancer</span> Cancer of the lining of the lips, mouth, or upper throat

Oral cancer, also known as mouth cancer, is a cancer of the lining of the lips, mouth, or upper throat. In the mouth, it most commonly starts as a painless white patch, that thickens, develops red patches, an ulcer, and continues to grow. When on the lips, it commonly looks like a persistent crusting ulcer that does not heal, and slowly grows. Other symptoms may include difficult or painful swallowing, new lumps or bumps in the neck, a swelling in the mouth, or a feeling of numbness in the mouth or lips.

<span class="mw-page-title-main">Submandibular gland</span> Human salivary gland

The paired submandibular glands are major salivary glands located beneath the floor of the mouth. In adult humans, they each weigh about 15 grams and contribute some 60–67% of unstimulated saliva secretion; on stimulation their contribution decreases in proportion as parotid gland secretion rises to 50%. The average length of the normal adult human submandibular salivary gland is approximately 27 mm, while the average width is approximately 14.3 mm.

<span class="mw-page-title-main">Head and neck cancer</span> Cancer arises in the head or neck region

Head and neck cancer develops from tissues in the lip and oral cavity (mouth), larynx (throat), salivary glands, nose, sinuses, or skin of the face. The most common types of head and neck cancer occur in the lips, mouth, and larynx. Symptoms predominantly include a sore that does not heal or a change in the voice. In those with advanced disease, there may be unusual bleeding, facial pain, numbness or swelling, and visible lumps on the outside of the neck or oral cavity. Given the location of these cancers, it is possible for an afflicted individual to experience difficulty in breathing.

<span class="mw-page-title-main">Xerostomia</span> Medical condition

Xerostomia, also known as dry mouth, is dryness in the mouth, which may be associated with a change in the composition of saliva, or reduced salivary flow, or have no identifiable cause.

<span class="mw-page-title-main">Parotitis</span> Medical condition

Parotitis is an inflammation of one or both parotid glands, the major salivary glands located on either side of the face, in humans. The parotid gland is the salivary gland most commonly affected by inflammation.

In biomedical contexts, a biomarker, or biological marker, is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated using blood, urine, or soft tissues to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers are used in many scientific fields.

In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. It may be defined as a "cellular, biochemical or molecular alteration in cells, tissues or fluids that can be measured and evaluated to indicate normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention." More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism. According to the WHO, the indicator may be chemical, physical, or biological in nature - and the measurement may be functional, physiological, biochemical, cellular, or molecular.

p16 Mammalian protein found in Homo sapiens

p16, is a protein that slows cell division by slowing the progression of the cell cycle from the G1 phase to the S phase, thereby acting as a tumor suppressor. It is encoded by the CDKN2A gene. A deletion in this gene can result in insufficient or non-functional p16, accelerating the cell cycle and resulting in many types of cancer.

<span class="mw-page-title-main">Salivary gland tumour</span> Medical condition

Salivary gland tumours, also known as mucous gland adenomas or neoplasms, are tumours that form in the tissues of salivary glands. The salivary glands are classified as major or minor. The major salivary glands consist of the parotid, submandibular, and sublingual glands. The minor salivary glands consist of 800 to 1000 small mucus-secreting glands located throughout the lining of the oral cavity. Patients with these types of tumours may be asymptomatic.

Oral and maxillofacial pathology refers to the diseases of the mouth, jaws and related structures such as salivary glands, temporomandibular joints, facial muscles and perioral skin. The mouth is an important organ with many different functions. It is also prone to a variety of medical and dental disorders.

Biotene is an over-the-counter dental hygiene product currently marketed by GlaxoSmithKline (GSK). It comes in a number of forms, including toothpaste, mouthwash and gel.

<span class="mw-page-title-main">Saliva testing</span>

Saliva testing or Salivaomics is a diagnostic technique that involves laboratory analysis of saliva to identify markers of endocrine, immunologic, inflammatory, infectious, and other types of conditions. Saliva is a useful biological fluid for assaying steroid hormones such as cortisol, genetic material like RNA, proteins such as enzymes and antibodies, and a variety of other substances, including natural metabolites, including saliva nitrite, a biomarker for nitric oxide status. Saliva testing is used to screen for or diagnose numerous conditions and disease states, including Cushing's disease, anovulation, HIV, cancer, parasites, hypogonadism, and allergies. Salivary testing has even been used by the U.S. government to assess circadian rhythm shifts in astronauts before flight and to evaluate hormonal profiles of soldiers undergoing military survival training.

<span class="mw-page-title-main">Cancer biomarker</span> Substance or process that is indicative of the presence of cancer in the body

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum.

<span class="mw-page-title-main">Salivary gland disease</span> Medical condition

Salivary gland diseases (SGDs) are multiple and varied in cause. There are three paired major salivary glands in humans: the parotid glands, the submandibular glands, and the sublingual glands. There are also about 800–1,000 minor salivary glands in the mucosa of the mouth. The parotid glands are in front of the ears, one on side, and secrete mostly serous saliva, via the parotid ducts, into the mouth, usually opening roughly opposite the second upper molars. The submandibular gland is medial to the angle of the mandible, and it drains its mixture of serous and mucous saliva via the submandibular duct into the mouth, usually opening in a punctum in the floor of mouth. The sublingual gland is below the tongue, on the floor of the mouth; it drains its mostly mucous saliva into the mouth via about 8–20 ducts, which open along the plica sublingualis, a fold of tissue under the tongue.

Porphyromonas pasteri is a Gram-negative, obligately anaerobic, non-spore-forming and non-motile bacterium from the genus of Porphyromonas which has been isolated from the human saliva. Porphyromonas pasteri is associated with periodontitis, a disease that can lead to tooth loss, and has also been linked to other systemic diseases such as cardiovascular disease, rheumatoid arthritis, and certain cancers.

References

  1. 1 2 "Meet Associate Professor Chamindie Punyadeera, real advocate for women in STEMM". Office of the Queensland Chief Scientist. 2019-05-24. Retrieved 2023-10-18.
  2. Punyadeera, Chamindie. "Chamindie Punyadeera". Mind and Body Performance Patch. Retrieved 2023-10-18.
  3. 1 2 Careers with STEM, STEM (2022-08-22). "Student essay: A true story of a female lead scientist". Careers with STEM. Retrieved 2023-10-18.
  4. Punyadeera, Chamindie. "Chamindie Punyadeera". Mind and Body Performance Patch. Retrieved 2023-10-18.
  5. "Grffith University - punyadeera". experts.griffith.edu.au. Retrieved 2023-10-18.
  6. "Professor Chamindie Punyadeera - Passe & Williams Foundation". gprwmf.org.au. Retrieved 2023-10-18.
  7. Zhang, Xi; Kulasinghe, Arutha; Karim, Rafid Shahriyar; Punyadeera, Chamindie (2015), Streckfus, Charles F. (ed.), "Saliva Diagnostics for Oral Diseases", Advances in Salivary Diagnostics, Berlin, Heidelberg: Springer Berlin Heidelberg, pp. 131–156, doi:10.1007/978-3-662-45399-5_7, ISBN   978-3-662-45398-8 , retrieved 2023-10-13
  8. Ovchinnikov, Dmitry A.; Wan, Yunxia; Coman, William B.; Pandit, Pratibala; Cooper-White, Justin J.; Herman, James G.; Punyadeera, Chamindie (2014). "DNA Methylation at the Novel CpG Sites in the Promoter of MED15 / PCQAP Gene as a Biomarker for Head and Neck Cancers". Biomarker Insights. 9: 53–60. doi:10.4137/BMI.S16199. ISSN   1177-2719. PMC   4085102 . PMID   25057238.
  9. "Chamindie Punyadeera FTSE". ATSE. Retrieved 2023-10-18.